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THIP (gaboxadol), a superagonist of the δ subunit-containing extrasynaptic GABAA
receptors, produces persistent neuroplasticity in dopamine (DA) neurons of the ventral
tegmental area (VTA), similarly to rewarding drugs of abuse. However, unlike them THIP
lacks abuse potential and induces conditioned place aversion in mice. The mechanism
underlying the aversive effects of THIP remains elusive. Here, we show that mild aversive
effects of THIP were detected 2 h after administration likely reflecting an anxiety-like
state with increased corticosterone release and with central recruitment of corticotropin-
releasing factor corticotropin-releasing factor receptor 1 (CRF1) receptors. A detailed
immunohistochemical c-Fos expression mapping for THIP-activated brain areas revealed
a correlation between the activation of CRF-expressing neurons in the oval nucleus of
the bed nuclei of stria terminalis and THIP-induced aversive effects. In addition, the
neuroplasticity of mesolimbic DA system (24 h after administration) and conditioned
place aversion by THIP after four daily acute sessions were dependent on extrasynaptic
GABAA receptors (abolished in δ-GABAA receptor knockout mice) and activation of the
CRF1 receptors (abolished in wildtype mice by a CRF1 receptor antagonist). A selective
THIP-induced activation of CRF-expressing neurons in the oval part of the bed nucleus of
stria terminalis may constitute a novel mechanism for inducing plasticity in a population
of VTA DA neurons and aversive behavioral states.
Keywords: GABA agonist, anxiety, aversive conditioning, glutamate neuroplasticity, VTA dopamine neurons,
CRF, BNST
Abbreviations: CRF1, corticotropin-releasing factor receptor 1; DA, dopamine; GABAA, γ-aminobutyric acid type A;
δ-KO, GABAA receptor δ subunit-knockout; δ-WT, GABAA receptor δ subunit-wildtype; ovBNST, oval part of the Bed
Nuclei of Stria Terminalis; THIP, [gaboxadol, 4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol]; VTA, ventral tegmental area.
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INTRODUCTION
Midbrain dopamine (DA) neurons participate in brain circuitries
that mediate many essential behaviors, such as attention and
cognitive performance, motivation, reinforcement and habit
formation, emotional and aversive processes, and regulate motor
coordination (Bjorklund and Dunnett, 2007). Ventral tegmental
area (VTA) DA neurons also play a critical role in initiating
reward-seeking behavior and constitute the common primary
target for the addictive drugs that exhibit high rewarding potency
(Schultz et al., 1997; Saal et al., 2003).
Many drugs of abuse induce persistent glutamate
neuroplasticity in the VTA DA neurons after a single
administration in rodents (Saal et al., 2003; Heikkinen et al.,
2009; Tan et al., 2010). While this can be mediated by local
processes in the VTA neurons and/or in surrounding nuclei,
primary effects from more remote brain regions cannot be
excluded at present. Interestingly, acute aversive stimulation
(foot pinch) reduces the VTA DA neuron firing (Ungless
et al., 2004), whereas a single short session of swimming
stress induces a similar persistent neuroplasticity in these
neurons as seen 1 day after administration of drugs of abuse
(Saal et al., 2003). Therefore, it has not been a surprise that
there are drugs that induce persistent neuroplasticity in VTA
DA neurons (lasting longer than the acute drug effect), but
are aversive or at least non-rewarding in behavior and not
self-administered by mice or baboons (Vashchinkina et al.,
2012). The VTA GABA neurons that express δ subunit-
containing GABA type A receptors (δ-GABAA) seem to be
preferentially inhibited by these drugs (Vashchinkina et al.,
2014), which may cause the activation of VTA DA neurons
by disinhibition.
One of these drugs is the GABAA receptor direct agonist THIP
[4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol, also known as
gaboxadol]. It is a superagonist (more efficient than GABA) at
extrasynaptic, tonically active δ-GABAA receptors (Brown et al.,
2002; Saarelainen et al., 2008; Mortensen et al., 2010), whose
translational significance as a therapeutic target is presently
searched for (Wafford and Ebert, 2008; Chandra et al., 2010;
Egawa et al., 2012; Rudolph and Möhler, 2014). THIP has
been considered as a potential treatment for alcohol and
cocaine dependance, essential tremor, pain and autism spectrum
disorders (Ramaker et al., 2011, 2014; Fritz and Boehm, 2014;
Maguire et al., 2014; Silverman et al., 2016; Handforth et al.,
2018; Liu et al., 2018; Rhine et al., 2019). Immunocytochemical
and in situ hybridization studies show expression of the δ
subunit-containing GABAA receptors e.g., in the bed nuclei
of stria terminalis (BNST), lateral habenula and hippocampus
(Wisden et al., 1992; Pirker et al., 2000; Hörtnagl et al., 2013)
that make circuit connections to VTA DA neurons (Watabe-
Uchida et al., 2012; Beier et al., 2015). Therefore, it is possible
that THIP activates neurons in these areas via disinhibitory
mechanisms leading to aversive behaviors and neuroplasticity in
the VTA DA neurons.
Here, we presented a detailed analysis of the events which
preceded the THIP-induced neuroplasticity in VTA DA neurons
and the conditioned aversive effects (Vashchinkina et al., 2012),
and were evident after the initial sedative phase i.e., at
2 h after the administration. We first found that THIP
induced a transient increase in stress-hormone corticosterone
blood level and, after an initial sedative phase, produced an
anxiety-mimicking behavior. Therefore, we then tested whether
selective blockade of corticotropin releasing factor corticotropin-
releasing factor receptor 1 (CRF1) receptors would eliminate
both THIP-induced neuroplasticity in VTA DA neurons and
conditioned place aversion in mice and examined whether
these effects were dependent on δ subunit-containing GABAA
receptors. Finally, we screened for activated brain areas using
c-Fos immunohistochemistry after acute THIP administration
at the neuroplasticity-inducing dose (Vashchinkina et al., 2012),
and revealed predominant activation of CRF-expressing neurons
in the dorsolateral part of the BNST as a possible correlate for
THIP-induced aversive, reward-reducing effects.
MATERIALS AND METHODS
Animals and in vivo Manipulations
We used transgenic Tyrosine Hydroxylase-EGFPmice (MMRRC
no. 000292-UNC; Gong et al., 2003), C57BL/6J mice (Charles
River), δ-GABAA receptor knockout (δ-KO) and wild-type
(δ-WT) littermate mice (Mihalek et al., 1999), and heterozygous
Somatostatin-IRES-Cre (Jax no. 013044) mice after breeding
with tdTomato reporter mice (Jax no. 007914; Madisen et al.,
2010). Age and gender of the mice are described in detail in the
following experimental protocols. The mice were weaned and
genotyped according to protocols provided by the breeders at the
age of 21 days and group housed (4–7 mice per cage), given free
access to standard rodent chow and water, and maintained on
a 12-h light/dark schedule (lights on 6:00–18:00). Habituation
to injections and testing conditions was carried out twice a
day using a small-volume saline injection (0.1 ml, i.p.) during
5 days. The mice were allowed to adapt to the test room for
at least 1 h before the experiments. All drug injections and
behavioral tests were performed between 08:00 and 10:00 h
unless otherwise stated. All animal procedures were approved
by the Southern Finland Provincial Government, and carried
out in accordance with the EU Directive 2010/63/EU for
animal experiments.
Behavioral Experiments
Habituated adult (11–13 weeks) male C57BL/6J mice were
injected either with THIP (6 mg/kg; gaboxadol hydrochloride,
H. Lundbeck A/S; dissolved in 0.9% saline) or saline vehicle. Two
hours later, individual exploratory behavior in the light-dark box
and open field was evaluated (Vekovischeva et al., 2013).
Light-dark exploration test was performed using a Med
Associates apparatus (Albans, VT, USA; Maksimovic et al.,
2014). The mouse was placed in the center of the lit area for
5 min, during which the duration and distance moved on the
lit and dark areas, the first latency to the lit area as well as the
number of entries into the dark area were recorded by a video-
tracking system (EthoVision; Noldus Information Technology,
Wageningen, Netherlands).
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Open-field test was performed for 6min immediately after the
light-dark test in a transparent plastic cage (33 × 55 × 19 cm;
for width, length and height, respectively), in which the floor
was divided into fifteen squares (11 × 11 cm) to specify
the 3-square center zone and the 12-square peripheral zone.
The test was subdivided into two parts. First, the animal was
put in the center and followed for 3 min. Second, a novel
object (a yellow plastic ball, 4 cm in diameter) was quickly
installed in the central square and the behavior observed for
an additional 3 min. Videos were analyzed using Ethovision
and Ethograph 2.06 software (Ritec, St. Petersburg, Russia)
according to Maksimovic et al. (2014). Behaviors were classified
as central or peripheral locomotion/behaviors or as new object
exploration including sniffing of the object, touching the
object by nose or forepaws and manipulating the object by
forepaws. The durations of locomotion on central or peripheral
zones and distance of the locomotor activities as well as the
latencies to the first entry into the center zone and to the
first contact with the object were registered as behavioral
markers of anxiety.
A biased place conditioning protocol was used to measure
THIP-induced conditioned place aversion in adult (11–15 weeks)
male δ-KO and δ-WT littermate mice (Siivonen et al., 2018;
Vashchinkina et al., 2018). Briefly, the schedule consisted of
three 15-min pre-conditioning tests to establish pre-preference to
either of two floor mat materials, two daily 30-min conditioning
sessions for 4 days, and a final 15-min post-conditioning test
to assess conditioned aversion in a cage with the two types of
floor mats bisecting the floor. Analysis of time that the mice
spent on each floor mat during the third pre-conditioning
test, revealed the preferred and non-preferred floor mats.
Conditioning sessions were performed over 4 days: morning
conditioning with the vehicle and evening conditioning
with the drugs. During the morning sessions (8:00–10:00),
the mice were pretreated with vehicle (5% Cremophor in
saline; Merck, Kenilworth, NJ, USA) and 30 min later with
saline and immediately placed on the preferred floor mat.
During the evening sessions (16:00–18:00), the mice were
pretreated either with the CRF1 receptor antagonist N-butyl-N-
ethyl-2,5-dimethyl-7-(2,4,6-trimethylphenyl)-7H-pyrrolo[2,3-d]
pyrimidin-4-aminemonohydrochloride (CP 154,526, 10 mg/kg,
Abcam, Cambridge, UK; dissolved in 5% Cremophor in saline)
or vehicle and 30 min later treated with THIP (6 mg/kg) and
placed on the non-preferred floor mat. Hence, there were
four treatment groups: δ-KO vehicle-saline/vehicle-THIP, δ-KO
vehicle-saline/CP-THIP, δ-WT vehicle-saline/vehicle-THIP, and
δ-WT vehicle-saline/CP-THIP. The post-conditioning test was
performed 48 h after the last conditioning session. Locomotor
activities and locations were determined by Ethovision. The
difference in time spent on the non-preferred material during
pre-conditioning and post-conditioning tests (i.e., time shift)
was calculated as the measure of place conditioning. Two
independent batches of adult mice were tested. CP 154,526 alone
does not affect place conditioning in mice (García-Carmona
et al., 2015; Lasheras et al., 2015).
Acute stress was elicited with a modified 6-min forced swim
task (Porsolt et al., 1977; Saal et al., 2003). Mice were placed in a
1-liter graduated cylinder containing 400 ml of water (22◦C) for
6 min, and then returned to their home cage.
Corticosterone Measurement
Adult male C57BL/6J (11–13 weeks) and both male and
female δ-KO (11–15 weeks) and the littermate wild-type
WT mice (n = 5–15) were used to determine the levels of
plasma corticosterone after either injection with vehicle or
THIP (6 mg/kg) or acute swimming stress. Mice were killed
by decapitation at 15, 45, and 90 min after injections or
45 min after acute swimming stress and trunk blood was
collected. Corticosterone was determined in duplicate samples by
enzyme immunoassay according tomanufacturer’s specifications
(Cayman Chemical, MI, USA).
Electrophysiological Experiments
Juvenile (22–29 days old) transgenic Tyrosine
Hydroxylase-EGFP mice were injected with either CP
154,526 (10 mg/kg) or vehicle and 30 min later with THIP
(6 mg/kg) or saline vehicle and decapitated 24 h later. Horizontal
225-µm-thick midbrain slices were prepared and preincubated
as described previously (Vashchinkina et al., 2012). VTA
DA neurons were visualized using fluorescence microscope
(Olympus BX51WI, Hamburg, Germany), and whole-cell
voltage-clamp recordings were performed with a Multiclamp
700A amplifier (Molecular Devices, Sunnyvale, CA, USA;
Vashchinkina et al., 2012). The currents were low-pass filtered at
1.6 kHz and digitized at 20 kHz (Molecular Devices). Electrodes
(3–4M) contained (in mM, pH adjusted to 7.2–7.25,
osmolarity to 280mOsm): 130 cesium methanesulfonate,
10 HEPES, 0.5 EGTA, 8 NaCl, 5 QX314, 4 MgATP, 0.3 MgGTP,
and 10 BAPTA. α-Amino-3-hydroxy-5-methyl-4-isoxazole
propionic acid (AMPA) and N-methyl-D-aspartate (NMDA)
receptor-mediated excitatory postsynaptic currents (EPSCs)
were induced by stimulating glutamatergic afferents at 0.1Hz
frequency using a bipolar stimulus electrode (Vashchinkina
et al., 2012). Neurons were clamped at +40mV under blockade
of GABAA receptors (picrotoxin, 100 µM; Tocris Bioscience,
Bristol, UK), and EPSCs were recorded at least for 10min
before and after the application of NMDA receptor blocker
D-(-)-2-amino-5-phosphonopentanoic acid (AP5 50 µM; Tocris
Bioscience). The ratio was calculated by dividing the peak
amplitude of AMPA receptor current (the peak current in the
presence of AP5) with that of NMDA receptor current (the peak
current calculated by subtracting the AMPA current from the
total AMPA+NMDA current), both currents averaged from
18 consecutive responses.
Immunohistochemistry
c-Fos immunohistochemistry was chosen as the method for
screening neuronal activation across brain regions since it has
been proven a useful tool to determine neuronal response
to GABAergic drugs and stress effects (Cullinan et al.,
1995; Panhelainen and Korpi, 2012). We used both juvenile
(27–29 days old) and adult (11–13 weeks) male C57BL/6J and
adult (11–15 weeks) male δ-KO and littermate δ-WT mice.
After 5-day habituation, on the day of the experiment, mice
were injected (i.p.) either with THIP (6 mg/kg) or vehicle in
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their home cages. Two hours later, when locomotor activity
of the THIP-treated mice had returned to the basal levels
(Vashchinkina et al., 2012), brains were dissected, frozen on dry
ice and stored at−80◦C. Coronal sections (14µm thick) were cut
with a cryostat (Leica CM 3050 S; Leica Microsystem, Nussloch,
Germany) and directly thaw-mounted on Fisher Superfrost Plus
slides (Menzel-Glaeser, Braunschweig, Germany), and stored at
−80◦C. Immunostaining was performed using the liquid bubble
technique (Procaccini et al., 2011), by incubating the sections first
in TBST containing 1% bovine serum albumin (BSA; Merck),
10% normal horse serum (Merck) and avidin blocking solution
(Avidin/Biotin blocking kit; Vector Laboratories, Burlingame,
CA, USA), and then with goat anti-c-Fos antibody (1:800; Santa
Cruz Biotechnology, Santa Cruz, CA, USA) in TBST containing
1% BSA and biotin blocking solution at 4◦C overnight. The next
day, the sections were incubated for 30 min in biotinylated horse
anti-goat secondary antibody (1:200; Vector Laboratories)
in TBST containing 1% BSA. c-Fos-positive cells were
visualized using avidin-biotin peroxidase complex (Vectastain
Standard Elite; Vector Laboratories) and diaminobenzidine
with nickel sulfate intensification (DAB Substrate kit; Vector
Laboratories). Sections were dehydrated in ethanol series,
immersed in Histoclear (National Diagnostic, Atlanta, GA, USA)
and coverslipped.
Using light microscopy, immunopositive cells were identified
by dense black nuclear staining in 19 brain areas (see Table 2),
confirmed by reference to a mouse brain atlas (Franklin and
Paxinos, 2008). For automatic detection of immunopositive cells
within regions of interest, we used constant thresholds for light
intensity and object size maintained across all animals with
ImageJ software (National Institutes of Health, Bethesda, MD,
USA). Four sections per mouse for each brain region were
counted (blind to the treatment) and averaged.
Finally, to determine the neurochemical identity of the
subsets of neurons activated by THIP in the oval BNST
(ovBNST), we performed dual cFos-CRF immunohistochemistry
on PFA-perfused brain sections from Somatostatin-IRES-Cre-
tdTomato mice, in which the somatostatin cells are labeled
with tdTomato. Following c-Fos staining as described above,
40-µm sections were incubated with the primary CRF antibody
(rabbit polyclonal anti-CRF, dilution 1:250, ab8901; Abcam,
Cambridge, UK), and then with the goat anti-rabbit IgG
Alexa Fluor 488 secondary antibody (dilution 1:1,000; A11008,
Life Technologies, Eugene, OR, USA). Confocal images were
acquired using full signal distribution with sequential channel
acquisition of each laser excitation on a Zeiss LSM 780 confocal
microscope (Carl Zeiss AG, Oberkochen, Germany). The
acquired images were analyzed with ImageJ software. Due to the
minuscule size of mouse ovBNST only one or two sections per
mouse for each treatment were counted (blind to the treatment)
and averaged for the outlined ovBNST.
Statistical Analyses
The results are presented as individual data points and
means ± SEM. Obtained data were analyzed with the IBM
SPSS Statistics 21 software (IBM, Armonk, New York, NY,
USA). First, the data were tested for the normal distribution
by Shapiro-Wilk test. If data points were normally distributed,
they were further analyzed by Student’s t-tests or multivariate
analysis of variance (ANOVA) followed by a Bonferroni test, or
otherwise by non-parametric Kruskal-Wallis test followed by a
Mann-Whitney test (p< 0.05).
RESULTS
THIP Induced Anxiety-Like State and
Increased Corticosterone Levels in
Wild-Type Mice, but Not in δ-GABAA-KO
Mice
First, we studied whether the dose of THIP (6 mg/kg) that
produces conditioned aversion and VTA DA neuron plasticity
(Vashchinkina et al., 2012) also induces acute anxiety-like effects
at 2 h after the treatment, when any sedative effects were
subdued (Vashchinkina et al., 2012). Particularly, we examined
anxiety-like behavior in the light-dark exploration and in the
open-field with novel object exploration tests and measured
plasma corticosterone levels in THIP-treated mice.
In the light-dark exploration test, we found a similar
basal performance between THIP-treated and control groups
(Table 1). The groups did not differ in total time spent in the lit
compartment nor in the distance moved in the compartments.
There were no significant differences in locomotor velocity
(Figure 1A, t-test, p = 0.26) nor in the number of crossings
between the compartments (Figure 1C, p = 0.50), i.e., no
THIP-induced sedation was anymore present. However, the
latency to enter the lit compartment was longer for THIP-treated
mice than vehicle-treatedmice (Figure 1B, p< 0.003), suggesting
that THIP induced anxiety-like effects.
In the open-field test, THIP-treated mice also did not show
any sedative signs compared with the control mice (Table 1,
total distance, p = 0.26; Figure 1D, velocity, p = 0.25). However,
both latencies to enter the center (Figure 1E, p < 0.002) and to
TABLE 1 | Anxiety-like behavior in light:dark exploration and open-field tests 2 h
after acute THIP treatment in adult male C57BL/6J mice.
Treatment
Behavior Vehicle THIP (6 mg/kg)
Light–dark exploration
Time spent in light (s) 43 ± 13 44 ± 9
Distance in light (cm) 710 ± 142 794 ± 104
Distance in dark (cm) 886 ± 130 1033 ± 90
Number of transitions 28 ± 4 32 ± 4
Open field
Peripheral locomotion
Total duration (s) 348 ± 3 346 ± 5
Total distance (cm) 1435 ± 134 1284 ± 72
Central locomotion
Total duration (s) 12 ± 3 14 ± 5
Total distance (cm) 140 ± 32 114 ± 16
Total frequency 7 ± 1 7 ± 1
Contact with the new object
Total duration (s) 4 ± 1 3 ± 1
Total frequency 5 ± 1 4 ± 1
Values are shown as means ± SEM (n = 7–11). Latency times are presented in Figure 1.
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FIGURE 1 | THIP acutely promoted anxiety-like behavior associated with increased plasma corticosterone levels in adult C57BL/6J mice. Mice were treated with
vehicle or THIP (6 mg/kg, i.p.) 2 h before assessing their behavior in light-dark exploration (A–C) and open field (D–F) tests; n = 7 and 11 mice treated with saline
vehicle and THIP, respectively; ∗∗p < 0.01 (t-test). (G) Time course of the effect of THIP treatment on plasma corticosterone level in adult C57BL/6J mice. Points are
means ± SEM for naïve mice n = 4; vehicle-treated mice at 15 min n = 6, at 45 min n = 6, at 90 min n = 5; THIP-treated mice at 15 min n = 6, at 45 min n = 8, at
90 min n = 6. ∗p < 0.05 for the difference from vehicle (Kruskal-Wallis test). (H) Corticosterone levels at 45 min after treatments with vehicle, THIP and acute
swimming stress in δ-WT and δ-KO mice. Basal corticosterone levels were not significantly different between δ-WT and δ-KO mice (p = 0.5). In contrast, THIP
treatment and acute stress increased corticosterone levels in δ-WT mice (p < 0.05), but not in δ-KO mice (p > 0.05). Scatter plots with means ± SEM,
n = 6–10 mice per group, ∗p < 0.05, ∗∗∗p < 0.001 for difference between treatments within the same genotype; #p < 0.01 for the difference between genotypes
after the same treatment [analysis of variance (ANOVA) with Bonferroni test].
explore the novel object (Figure 1F, p < 0.008) were longer in
THIP-treated mice than in vehicle-treated ones. Thus, both these
tests revealed a mild anxiety state after the acute sedative phase
of THIP treatment.
We next measured corticosterone levels to test a hypothesis
that THIP-induced anxiety-like negative sensations were
associated with activation of stress mechanisms. We first
determined the time course of plasma corticosterone
changes after acute injection of THIP and vehicle in adult
wild-type mice (Figure 1G). Although the injections increased
the corticosterone levels as compared to naïve controls, the
vehicle treatment did not further affect the levels at 15,
45 or 90 min after the injection. On the contrary, THIP
treatment induced a transient increase at 45 min (Figure 1G,
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Kruskal-Wallis, p = 0.003). Notably, we observed the increase
in corticosterone at the time when behavioral sedation after
THIP started to subdue in comparison to saline-treated mice
(Vashchinkina et al., 2012).
We then compared plasma corticosterone levels in δ-KO
mice and their δ-WT littermates at 45 min after THIP injection
and after 6-min swimming exposure, which is known to be
stressful for mice (Timpl et al., 1998). Two-way ANOVA showed
significant effects of mouse line (F(1,35) = 19.7, p < 0.0001) and
treatment (F(2,35) = 9.5, p < 0.001) on the corticosterone levels,
but no interaction (F(2,35) = 1.7, p = 0.19). In the WT mice,
corticosterone increased similarly by THIP injection and acute
stress as compared to vehicle injection (Figure 1H). On the
contrary, within δ-KO mice, the treatment groups did not differ
from each other and the corticosterone in δ-KO vehicle-treated
group was not different from that in WT vehicle-treated group.
The corticosterone level in δ-KOTHIP group was lower than that
in the corresponding WT THIP group (p< 0.01).
All in all, the similarly increased corticosterone levels after
THIP treatment and acute stress suggest that the treatment in
mice induced a peripheral stress response that appeared generally
blunted in the δ-KO mice.
Blockade of CRF1 Receptor-Mediated
Signaling Interrupts THIP-Induced
Conditioned Place Aversion and
Neuroplasticity in VTA DA Cells
After revealing that THIP treatment was associated with
anxiety-like effects and elevated plasma corticosterone levels,
we next studied whether selective pharmacological blockade of
the CRF transmission is sufficient to inhibit THIP treatment-
induced conditioned place aversion in δ-WT and δ-KO mice
(Vashchinkina et al., 2012). To test this hypothesis, we pretreated
mice with CRF1 receptor antagonist CP 154,526 (10 mg/kg, i.p.)
30 min prior to conditioning them to THIP (6 mg/kg, i.p.).
In line with our previous study (Vashchinkina et al., 2012),
vehicle-pretreated δ-WTmice expressed the THIP-induced place
aversion, whereas no place aversion or preference was observed
in δ-KO mice (Figure 2A; genotype F(3,42) = 5.7, p = 0.02).
In conditioning sessions, while δ-WT and δ-KO mice showed
similar locomotor activity during morning vehicle sessions
(genotype F(1,44) = 0.35, p = 0.55; pretreatment F(1,44) = 1.2,
p = 0.26), the δ-WT mice had lower activity than the δ-KO
mice during evening THIP sessions (genotype F(1,44) = 10.0,
p = 0.003). Pretreatment with CP 154,526 did not affect this
locomotor activity (F(1,44) = 2.0, p = 0.16). Pretreatment with CP
154,526 abolished the THIP-induced conditioned place aversion
in δ-WT mice, while there was no change in δ-KO mice
(pretreatment F(3,42) = 4.3, p = 0.04, pretreatment × genotype
interaction F(3,42) = 1.1; p = 0.23). Locomotor activities during
the test trial were similar between the genotypes (Figure 2B;
genotype F(3,42) = 2.4, p> 0.05).
Since the same dose of THIP treatment also induces
persistent neuroplasticity in VTA DA neurons (Vashchinkina
et al., 2012), we next examined whether the pretreatment with
CP 154,526 (10 mg/kg, i.p.) would attenuate THIP-induced
plasticity in these neurons. As predicted, THIP treatment
induced a significant increase in the AMPA/NMDA receptor
current ratios ex vivo in the VTA DA neurons from WT mice
(Figures 2C,D). There was no difference in the ratio between the
two vehicle groups pretreated with CP 154,526 and the earlier
recorded vehicle group (Vashchinkina et al., 2012), whereas
CP 154,526 completely blocked the THIP treatment-induced
increase in the ratio (Figures 2C,D, F(1,15) = 8.1, p < 0.01).
Together, these results provide evidence that the recruitment of
CRF1 receptors was selectively required to mediate the aversive
response to THIP.
Selective Activation of the Oval BNST CRF
Neurons in the Response to Aversive THIP
Effects
We then determined the brain areas that were activated (or
suppressed) after administration of THIP (6 mg/kg), in order
to understand the possible neuronal circuitry underlying the
aversive behavioral effect and elevated corticosterone levels.
Neuronal activation was measured by detection of c-Fos
expressing nuclei in various brain areas enriched with δ-GABAA
receptors and CRF (Pirker et al., 2000; Rodaros et al., 2007;
Hörtnagl et al., 2013). The effects of THIP on c-Fos expression
at 2 h after the injection are shown in Table 2. THIP
altered neuronal activity in a brain region-specific manner
(Table 2; Kruskal-Wallis, p < 0.005). Particularly, in juvenile
mice, a significant increase in the number of c-Fos-positive
neurons was observed in the BNST (sections corresponding to
bregma 0.14 mm, Mann-Whitney p < 0.001), central amygdala
(CeA, p < 0.001), thalamic paraventricular nucleus (PVT,
p = 0.001) and hypothalamic paraventricular nucleus (PVN,
p = 0.004). In adult mice, we observed significantly increased
c-Fos expression only in the BNST, which forms part of the
extended amygdala (Table 2, p = 0.05). We did not observe
any decreases of c-Fos expression in mice, consistent with a
low level of baseline c-Fos expression after vehicle injection in
habituated mice.
We then repeated the study using δ-KO mice to ascertain
whether c-Fos expression in THIP-treated mice was dependent
on the δ-GABAA receptor-mediated responses. In δ-WT mice,
c-Fos expression was increased only in the BNST complex. This
effect was not found in δ-KO mice (Figures 3C,D, Kruskal-
Wallis, p = 0.03). Notably, c-Fos expression was not altered
in any other brain region examined after vehicle or THIP
treatment (data not shown). Respecting the anatomical and
functional complexity of the BNST (Dong and Swanson, 2006,
and references cited therein), we performed an analysis of the
BNST subregions (Figures 3A,B). Elevated c-Fos expression in
WT mice after the THIP treatment was found particularly in
the ovBNST (Mann-Whitney, p = 0.005). This effect was not
detected in δ-KO mice (Figures 3C,D, p > 0.05), indicating
THIP selectively activated neurons in the ovBNST in a manner
dependent on δ-GABAA receptors.
The ovBNST nucleus has been reported to have several
cell types that integrate information about mood and negative
valence via several neurotransmitters and peptides including
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FIGURE 2 | Pretreatment with corticotropin-releasing factor receptor 1 (CRF1) receptor antagonist, CP 154,526, attenuated THIP-induced conditioned place
aversion and glutamate neuroplasticity in ventral tegmental area (VTA) dopamine (DA) cells. (A) Vehicle-pretreated δ-WT mice conditioned with THIP expressed place
aversion (spent less time with initially non-preferred floor mats) at 48 h after the last conditioning session, while those conditioned after CP 154,526 pretreatment
failed to express any preference or aversion. The δ-KO mice conditioned with THIP failed to express aversion independent of the pretreatment. (B) Locomotor activity
during the final test trial. Scatter plots with means ± SEM, n = 10–12. ∗p < 0.05 for the difference between treatments within the same genotype; #p < 0.05 for the
difference between genotypes after the same treatment (ANOVA with Bonferroni test). (C) Examples of α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid
(AMPA) and N-methyl-D-aspartate (NMDA) receptor-mediated current traces recorded 24 h after treatment with vehicle + saline, vehicle + THIP (6 mg/kg) and CP
154,526 (10 mg/kg) + THIP in transgenic Tyrosine Hydroxylase-EGFP mice. Scale bars represent 20 pA and 50 ms. (D) Averaged data show THIP-induced the
increase of AMPA/NMDA (A/N) ratios in VTA DA neurons for mice pretreated with vehicle, but not for those pre-treated with CP 154,526. Scatter plots with
means ± SEM, n = 5–7. ∗p < 0.05, ∗∗p < 0.01 (ANOVA with Bonferroni test).
GABA, CRF and Somatostatin (Bota et al., 2012; Kim et al., 2013).
On that basis, we further identified the type of c-Fos-positive cells
by analyzing co-localization of c-Fos with CRF and Somatostatin
in THIP-treated ovBNST sections. In line with previous
experiment, THIP induced a robust c-Fos expression compared
to their controls (Figure 4A, Mann-Whitney, p = 0.02). The
majority of the c-Fos-positive cells examined were CRF-positive
(Figures 4B,C: 84 of 131 cells; 64%). Interestingly, a third of the
c-Fos-positive cells (23 of 84; 27%) co-expressed Somatostatin,
whereas only the minority (8 of 131; 6%) expressed Somatostatin
and not CRF. Collectively, these data demonstrate that THIP
preferentially activated the ovBNST CRF-expressing neurons in
the δ-GABAA receptor-dependent manner.
DISCUSSION
The aim of the present study was to demonstrate which events
preceded the persistent THIP-induced neuroplasticity in VTA
Frontiers in Molecular Neuroscience | www.frontiersin.org 7 May 2019 | Volume 12 | Article 130
de Miguel et al. Extrasynaptic GABAARs and ovBNST Activation
TABLE 2 | Brain regional expression of c-Fos 2 h after THIP treatment in juvenile and adult male C57BL/6J mice.
Brain area Juvenile mice Adult mice
Vehicle THIP (6 mg/kg) Vehicle THIP (6 mg/kg)
Cortical areas
Prelimbic cortex 2.4 ± 1.1 4.4 ± 1.1 3.5 ± 1.1 7.5 ± 1.7
Hippocampus
CA1 2.7 ± 2.0 0.6 ± 0.3 0.7 ± 0.4 2.4 ± 0.6
CA3 17.0 ± 6.6 19 ± 11 5.4 ± 1.5 10 ± 2.3
DG, granular layer 1.7 ± 0.6 3.9 ± 2.8 0.1 ± 0.1 0.2 ± 0.2
DG, polymorph layer 1.3 ± 0.5 2.8 ± 1.8 1.3 ± 0.5 1.6 ± 0.5
Extended amygdala
Basolateral nucleus 1.3 ± 0.2 3.0 ± 0.5 2.7 ± 0.8 5.1 ± 1.2
Central nucleus of amygdala 0.6 ± 0.1 3.6 ± 1∗∗ 1.0 ± 0.7 2.8 ± 0.8
BNST 2.2 ± 0.5 12 ± 2.7∗∗∗ 1.9 ± 0.6 5.9 ± 1.6∗
Midbrain
Periaqueductal gray 28.7 ± 9.2 32.0 ± 7.0 40 ± 15 43 ± 12
Substantia nigra, reticulata 0.5 ± 0.3 0.2 ± 0.1 1.1 ± 0.5 1.5 ± 0.6
Substantia nigra, compacta 1.9 ± 0.5 1.6 ± 0.5 3.0 ± 1.0 6.0 ± 1.9
Ventral tegmental area 0.5 ± 0.1 0.7 ± 0.2 1.2 ± 0.8 2.6 ± 0.7
Hypothalamus
Dorsomedial nucleus 8.1 ± 1.5 19.7 ± 2.5 4.3 ± 1.1 11.2 ± 3
Paraventricular nucleus (PVN) 5.1 ± 1.7 24.6 ± 9.2∗ 14.2 ± 5.2 25.5 ± 7.7
Ventromedial nucleus 4.6 ± 0.8 8.3 ± 1.9 3.6 ± 1.9 4.2 ± 1.1
Thalamic areas
Paraventricular nucleus (PVT) 28.5 ± 5.4 68 ± 8∗∗∗ 15.1 ± 3.5 39 ± 10
Central medial nucleus 10.7 ± 6.2 32.9 ± 17 4.7 ± 1.1 9.8 ± 2.4
Mediodorsal nucleus 9.7 ± 5.6 13.6 ± 3.6 2.7 ± 1.4 1.2 ± 0.8
Habenula 1.1 ± 0.3 3.1 ± 1.1 2.4 ± 0.8 2.9 ± 0.8
Values are means ± SEM (n = 7–8 mice) for the number of c-Fos-positive cells/0.1 mm2. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 (Kruskal-Wallis test followed by Mann-Whitney
post hoc test).
DA neurons and the following conditioned aversive effects. We
found that a moderate dose of THIP acutely induces negative
anxiety-like effects, a component of the negative emotional
state, with transient central and peripheral recruitment of
stress mechanisms. Elevated levels of corticosterone are
known to drive anxiety-like behaviors (Mitra and Sapolsky,
2008). Furthermore, the long-term aversive sequelae of
THIP could be prevented by specifically antagonizing the
CRF1 receptors. Using immunohistochemistry, activation
of CRF-expressing neurons in the ovBNST correlated with
THIP-induced aversive effects. Thus, our results indicate that
acute effects of THIP at the dose leading to neuroplasticity
and conditioned aversion are associated with activation of
stress pathways.
THIP has been thoroughly studied as an anxiolytic agent,
but it has failed to demonstrate effectiveness when compared
to benzodiazepine-site compounds. Namely, in patients with
chronic anxiety, ‘‘the anxiolytic effects of THIP appeared
to be weak and occurred at or close to the dose levels
which induced sedation and undesirable side effects’’ (Hoehn-
Saric, 1983). In several rodent studies, only low doses of
THIP (1.25–4 mg/kg) showed anxiolytic effects in 30–45 min
after the drug administration (e.g., Gulinello et al., 2003;
Elfline et al., 2004; Saarelainen et al., 2008). Noteworthy,
THIP treatment was more efficient in the anxiety-predisposed
animals, whereas in the wild types THIP hardly produced
any anxiolytic-like effects (Gulinello et al., 2003; Saarelainen
et al., 2008). In the present study, the mice were treated
with a higher dose of THIP (6 mg/kg) and the drug effect
was screened at 2 h after the drug administration. Thus,
the present data extend the previous results by showing
anxiogenic effects and prolonged neuroplasticity of a higher
dose of THIP.
The CRF system is a tangible player of the stress response,
exerting its effects through the CRF1 and the CRF2 receptor
subtypes (Hauger et al., 2003). Importantly, the CRF1 and
the CRF2 receptors induce distinct effects on emotional
behavior (Tran et al., 2014). Namely, CRF1 receptor mediates
anxiogenic-like effects of CRF (Müller et al., 2003), while CRF2
receptor activation mediates either anxiolytic or anxiogenic
effects, or has no effects (Coste et al., 2000; Bale and Vale, 2004;
Cooper and Huhman, 2005). Furthermore, many studies suggest
that overactivation of the extrahypothalamic CRF–CRF1 system
may constitute a common player in the negative motivational
aspects of drug withdrawal (George et al., 2007). Because
CRF has a higher affinity for CRF1 than CRF2 receptors
and higher concentrations of CRF are required to activate
both receptor subtypes (Chalmers et al., 1995), we focused
on the CRF1 receptor. As intended, we found that selective
pharmacological inhibition of CRF1 receptors prior to THIP
treatment completely blocked THIP-induced conditioned place
aversion and neuroplasticity in VTA DA neurons of WT mice,
indicating an overactivation of the central CRF–CRF1 system
after THIP treatment.
In c-Fos mapping experiment, we were able to screen the
numerous brain regions involved in the negative emotional
state after THIP treatment. In juvenile mice, we obtained some
c-Fos activation of the extrahypothalamic CRF system, including
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FIGURE 3 | THIP-induced c-Fos expression was detected specifically in the ovBNST in wild type littermates (WT), this effect being abolished in δ-KO mice.
(A,B) Schematic diagrams of the brain sections (Franklin and Paxinos, 2008) showing levels of analyzed regions of the BNST. (C) Effects of THIP (6 mg/kg) and
vehicle (Veh) treatments on the c-Fos expression 2 h after injection in subdivisions of the BNST of adult WT and δ-KO mice. Scatter plots with means ± SEM,
n = 6–8 mice per group, ∗∗p = 0.005 for the significance of difference from the corresponding vehicle treatment, and ###p < 0.001 from the corresponding WT value
(Kruskal-Wallis with Mann-Whitney test). (D) Representative immunostaining of c-Fos after THIP and Veh in the ovBNST of WT and δ-KO mice. Scale bar = 100 µm.
ovBNST, oval BNST; jxBNST, juxtacapsular BNST; adBNST, anterodorsal BNST; vBNST, ventral BNST; mBNST, medial BNST; lBNST, lateral BNST; aca, anterior
commissure; ic, internal capsule.
the CeA, the PVT and the BNST, as well as the PVN, a
part of hypothalamic-pituitary-adrenal axis (Zhang et al., 1996;
Padilla-Coreano et al., 2012; Lee et al., 2014). In adult mice,
we observed c-Fos activation to be localized only in the BNST,
although there was a trend towards elevated c-Fos in the CeA,
PVN and PVT consistent with the results on juvenile mice. The
more pronounced effects on c-Fos in juvenile mice might be
explained by these mice being more sensitive to the effects of
THIP than the adults (Vashchinkina et al., 2012).
In fact, the BNST is a uniquely positioned brain region
to integrate the brain processes of anxiety/stress with
reward/motivation circuitry through modulation of the
firing rate of VTA DA neurons (Stamatakis et al., 2014).
The BNST is involved in drug withdrawal and dysphoria-
triggered relapse (Koob, 2003). Within the BNST nuclei
(Dong et al., 2001), we found that the ovBNST in the
dorsolateral BNST showed particularly increased number
of c-Fos-positive cells after THIP treatment. Importantly,
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FIGURE 4 | Immunohistochemical characterization of c-Fos positive cells in ovBNST in THIP-treated mice. Immunohistochemical staining for corticotropin-releasing
factor (CRF, green) in BNST sections of Somatostatin-tdTomato (red) mice revealed that 64% c-Fos-expressing cells in the ovBNST, activated by THIP treatment,
also express CRF. (A) Triple fluorescence labeling of CRF (green), Somatostatin (red, Sst) and c-Fos protein (black nuclei) in the ovBNST at high magnification. Scale
bar: 100 µm. aca, anterior commissure; ic, internal capsule. (B) In line with the previous experiment (Figure 3), THIP induced a robust c-Fos activation in the
ovBNST. The total number of c-Fos+ cells in the ovBNST are given as individual data points with means ± SEM, n = 5 and 4 mice treated with saline vehicle (Veh)
and THIP, respectively; ∗∗p = 0.01 (t-test). (C) A pie chart representing the fractions of CRF/c-Fos+ (green), Sst/c-Fos+ (red), CRF/Sst/c-Fos+ (orange) and
non-identified c-Fos+ (gray) cells in THIP-treated mice (n = 4).
the ovBNST activation has been associated with both acute
and chronic stress reactions (Dabrowska et al., 2013; Ide
et al., 2013; Kim et al., 2013; Roman et al., 2014). Selective
optogenetic activation of the ovBNST neurons was able to
induce avoidance of open spaces in the anxiety tests and increase
the respiratory rate, indicating an anxiogenic function of the
ovBNST (Kim et al., 2013).
We further demonstrated here that the THIP treatment-
induced conditioned place aversion (Vashchinkina et al.,
2012) was dependent on expression of δ-GABAA receptors, in
line with a key role of δ-GABAA receptors in the negative
affective effects of THIP (Sarkar et al., 2011). Present
results suggest that the lack of ovBNST activation by THIP
in the δ-KO animals may explain deficient aversive place-
conditioning and neuroplasticity of the VTA DA neurons. Due
systemic administration of the CRF1 receptor antagonist it
is not possible to conclude that the ovBNST CRF-signaling
mediated the THIP treatment-induced CPA, although
administration of CRF into the dorsolateral BNST (ovBNST
being part of it) is known to be sufficient in producing
CPA, whereas administration of CRF receptor antagonist
suppresses pain-induced CPA (Ide et al., 2013). Hence, the CRF
signaling in/from the ovBNST is likely involved in the effects of
THIP treatment.
In the VTA, CRF1 receptors have been shown to modulate
both GABA and glutamate release (Beckstead et al., 2009; Harlan
et al., 2018). The CRF1/protein kinase C/hyperpolarization-
induced cation channel HCN pathway represents a plausible
explanation for modulation of the THIP-induced plasticity in
VTA DA cells (Wanat et al., 2008; Figure 5). It remains to
be studied whether CRF1 activation is sufficient in stimulating
of the phospholipase C-protein kinase C (PLC–PKC) signaling
pathway, which enhances Ih currents and increases the firing rate
of VTA DA neurons (Wanat et al., 2008).
One primary neuronal target population for THIP might
be the central amygdala interneurons that express functional
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FIGURE 5 | A hypothetical mechanism of action of sedative doses of THIP
on the δ-GABAA receptors, followed by activation of CRF neurons in the
ovBNST and persistent neuroplasticity in DA neurons of the VTA. Briefly, THIP
selectively activates the ovBNST CRF neurons via disinhibition of one of the
GABAergic inputs to ovBNST, which are enriched with δ-GABAA receptors
(e.g., in the central nucleus of amygdala, CeA). The release of CRF on VTA DA
cells and signaling through CRF1 receptor/PKC/HCN pathway might increase
firing rate and induce excitatory synapse neuroplasticity in VTA DA neurons.
δ-GABAA receptors (Herman et al., 2013). This interneuron
population inhibits the central amygdala projection neurons that
express CRF1 receptors and project to the BNST. When these
interneurons are inhibited by THIP, the projection neurons are
disinhibited, producing an activation in the BNST (Herman
et al., 2013). This activation, in turn, may be sufficient to
induce anxiogenic behavior (Walker and Davis, 2008). Thus, the
central amygdala-BNST circuitry is likely to be involved in the
aversive effects of THIP in adult mice, and in neuroplasticity-
inducing effects in juvenile mice, perhaps in association with
CRF-signaling and δ-GABAA receptor activation in the PVT
[a part of extrahypothalamic CRF system (Zhang et al., 1996;
Padilla-Coreano et al., 2012)] and PVN [a part of hypothalamic-
pituitary-adrenal axis (Lee et al., 2014)].
The ovBNST harbors one of the highest densities of
CRF-expressing neurons within the BNST complex, receiving
many CRF inputs from the central amygdala (Sakanaka et al.,
1986; Beckerman et al., 2013). Furthermore, the ovBNST is
among the brain regions sending CRF-positive projections to the
VTA GABA neurons (Rodaros et al., 2007). Indeed, additional
immunohistochemical analysis of the ovBNST revealed that
after THIP treatment 64% of c-Fos positive cells were
CRF-expressing neurons. These CRF-expressing neurons are
within a predominantly GABAergic nucleus, suggesting that
local interneurons could provide an inhibitory control over
the output of the CRF neurons (Daniel and Rainnie, 2016).
Notably, direct application of THIP into the BNST induces
a robust tonic current in the ovBNST CRF-negative neurons,
but not in the ovBNST CRF-expressing neurons (Partridge
et al., 2016). It is thus possible that THIP induces disinhibition
of the ovBNST CRF-expressing neurons, leading to aversive
behavior and VTA neuroplasticity. In fact, selective optogenetic
activation of the subpopulation of ovBNST CRF-expressing
neurons is sufficient to promote anxiety-like state in mice
(Kim et al., 2013). Further study is needed to establish
the exact circuitry and complex connections of the BNST
(Stamatakis et al., 2014) that are involved in THIP-induced
behavioral effects.
Of note, withdrawal from abuse of a variety of drugs,
including alcohol, opioids and stimulants has also a strong
effect on neuronal excitability in the BNST subnuclei (Koob,
2003), with especially CRF/CRF1 receptor and noradrenergic
mechanisms within the BNST being involved (Aston-Jones
et al., 1999; Walker and Davis, 2008). Thus, the observed THIP
effects could have been related to its acute withdrawal effects.
Early preliminary pharmacokinetics data in mice showed a long
half-life of 1.4 h for oral THIP (5 mg/kg), based on thin-layer
chromatographic analysis of elimination of 14C-labeled THIP
to urine (Schultz et al., 1981), but much faster kinetics in rat
plasma and brain with half-lives of only about 30 min have
been reported using more selective LC/MS analytical methods
(Cremers and Ebert, 2007). Physiologically, it has been found
that THIP (4 and 6 mg/kg, i.p.) produces prolonged changes
in the cortical EEG activity for 2–3 h in mice, which effects
are absent in δ-KO mice (Winsky-Sommerer et al., 2007).
In summary, whether THIP-induced ovBNST activation and
persistent neuroplasticity in the VTA are produced directly
via its acute actions or are resulting from neuroadaptation
effects initiated by the acute actions, remain unresolved in the
present study.
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Acute stressors per se, such as forced swimming and restraint
stress, do not elevate c-Fos expression in the ovBNST (Cullinan
et al., 1995). Although chronic THIP treatment has not been
reported to produce a significant withdrawal syndrome (Lancel
and Langebartels, 2000; Mathias et al., 2005), it is possible
that in the present study the elevated c-Fos expression within
the ovBNST and the anxiety-like behavior were linked to a
neuroadaptation process after a single acute THIP dose. The
BNST is strongly involved in withdrawal states from drugs of
abuse through distinct pathways. Particularly, ethanol recruits
the juxtacapsular BNST (jxBNST), which displays connectivity
different from the ovBNST (Francesconi et al., 2009). Another
study showed involvement of glutamatergic transmission onto
VTA-projecting BNST CRF-neurons after ethanol withdrawal
(Silberman et al., 2013). Morphine withdrawal induces c-Fos
expression in the anterior-medial and jxBNST and CeA, and
lesions of the CeA reduce c-Fos expression in the BNST,
whereas lesions of the BNST have no effect on c-Fos expression
in the CeA (Nakagawa et al., 2005). It is possible that the
THIP-induced aversive state could be used to down-regulate
positive reinforcing effects of drugs of abuse, either at early phase
of positive reinforcement or during the delayed post-dependent
phase with regained overactivity of the mesolimbic DA system
(Hirth et al., 2016).
To our knowledge, no study has reported clear anxiolytic
or anxiogenic effects induced by other compounds activating
extrasynaptic δ-GABAA receptors (e.g., ganaxolone, AA29504,
and DS2). Thus, further work is needed to determine whether
the observed aversive behavior and activation of the ovBNST
are induced by the specific compound studied here (THIP) or
whether these effects are commonly produced by all compounds
in this drug class.
Taken together, our results suggest that the THIP
treatment-induced VTA DA neuron plasticity and aversive
behavioral effects required both δ-GABAA and CRF1 receptors.
The development of anxiety-like effects of THIP is associated
with activation of the ovBNST CRF-expressing neurons,
suggesting a mechanism for an aversive process activating a
population of VTA DA neurons. These findings provide further
understanding of mechanisms of the drugs selectively targeting
δ-GABAA receptors and drug-induced aversive states.
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